InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: skweze post# 174298

Thursday, 04/24/2014 6:34:15 PM

Thursday, April 24, 2014 6:34:15 PM

Post# of 345554
so I think many here will be looking back at these days and we will be saying the same thing...

did we buy under $2 ?

or did we sell under $2 ?

I think I have a very good idea who the geniuses will be..... : ) of course, the real genius was the late Dr. Philip Thorpe!

Interesting that the FDA is forcing Big Pharma to reveal more and all the pre-clinical studies / clinical data so everyone gets to see the good and the bad. Maybe the Bavi+Yervoy trial will finally prove that there is a way to hide the side affects... by targeting PS before/during/and after treatment.

Peregrine has the right drug at the right time and Peregrine just sits and waits.... at that epicenter : )

Eruption can occur at anytime.... stand back.


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News